Clinical observation of acupoint application in the treatment of diarrhea-type irritable bowel syndrome
- Conditions
- Irritable bowel syndrome
- Registration Number
- ITMCTR2200006666
- Lead Sponsor
- Tianjin Public Security Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Between the ages of 18 and 75, male and female; It met the diagnostic criteria of Rome ? diarrheal IBS subtype; It meets the diagnosis standard of the syndrome of liver stagnation and spleen deficiency in traditional Chinese medicine; The baseline IBS-SSS score is not less than 75; Patients volunteered to participate in the study and signed informed consent.
Diarrhoea due to other clearly diagnosed diseases, such as peptic ulcer disease, inflammatory bowel disease, tumour, etc.; Patients with serious diseases of liver, kidney, nerve, cardiovascular, respiratory and other organs or systems; Allergic to the drugs used in the protocol; Women in pregnancy; Mental illness, intellectual disability, education level and other reasons can not be surveyed; Those who have received drugs that may affect the judgment of curative effect in the past week, such as antispasmodic drugs, antidiarrhoetics, probiotics, antibiotics, anti-depressant and anxiety drugs, etc.; Patients with severe skin diseases, skin damage or poor glycemic control in the application area; Patients who are enrolled in another clinical trial or have completed another clinical trial for less than 3 months.
Those who satisfy one or more of the above requirements will be excluded.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method